| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.098 | 0.4 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.4 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |